Connect With a Global Community of Experts
Engage with a Highly Targeted Audience
Connect directly with senior leaders in oligonucleotide chemistry, delivery, CMC, safety, and regulatory strategy, all actively seeking partners to overcome challenges in capacity, timelines, bioavailability, and quality to accelerate their programs.
Showcase Your Chemistry, Delivery & Development Expertise
Highlight your solutions in innovative oligo design, precision delivery, and scalable manufacturing, demonstrating how you tackle industry bottlenecks such as long development timelines, off-target effects, and difficulties translating candidates into the clinic.
Position Your Brand as a Trusted Strategic Partner
Build credibility as a go-to collaborator who delivers what matters most: competitive cost, predictable timelines, transparency, and uncompromising quality, helping advance safer, more effective RNA-based medicines.
What You Missed
Distinguish Yourself from the Crowd
Stand out to senior decision-makers by showcasing your innovative solutions, thought leadership, and ability to tackle the biggest challenges in oligonucleotide therapeutics.
Demonstrate Your Expertise
Present your work within our program, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company’s unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs, get insights and competitor strategies to shape your organisations competitive edge.
Meet New Clients
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Key Services & Solutions:
Our attendees from Novo Nordisk, Dyne Therapeutics, Genentech and more are looking for service and solution providers with capabilities in the below areas but not limited to:
- Providing oligonucleotide synthesis capabilities at both R&D and commercial scale-up stages of drug development.
- Raw starting materials for synthesising oligos
- Clinical CRO expertise addressing inherent toxicity and safety challenges
- This community need leading CDMOs for ASO and siRNA synthesis, to ensure top-quality production and robust analytical assessments.
- State of the art in vivo models, highlight the uniqueness and reliability of your models, ensuring robust preclinical data.
Attending Companies Included
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.